TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 22979932

Group type: EXPERIMENTAL
Intervention: Acupuncture treatment for dry eye (3 weeks duration)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Artificial tear therapy (control group, 3 weeks duration)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Acupuncture treatment (1 week after treatment)
Number of subjects: 65
Study: 19203163

Group type: EXPERIMENTAL
Intervention: Multisystemic therapy (MST)
Number of subjects: 127

Group type: COMPARATOR
Intervention: Treatment as usual for juvenile sexual offenders (TAU-JSO)
Number of subjects: 127
Study: 17301733

Group type: EXPERIMENTAL
Intervention: Grapefruit juice (300 ml) with 120 mg fexofenadine
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Aqueous solution of naringin (1,200 microM) with 120 mg fexofenadine
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Grapefruit juice with 120 mg fexofenadine
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Particulate fraction of juice with 120 mg fexofenadine
Number of subjects: 12

Group type: COMPARATOR
Intervention: Water
Number of subjects: 12
Study: 15333083

Group type: EXPERIMENTAL
Intervention: Dobutamine infusion
Number of subjects: 20
Study: 11584487

Group type: EXPERIMENTAL
Intervention: Acupressure at the Neiguan point (P6)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Acupressure at a placebo point
Number of subjects: 60

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 60
Study: 9855523

Group type: EXPERIMENTAL
Intervention: Amitriptyline
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: Mexiletine
Number of subjects: 145

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 145
Study: 7924123

Group type: EXPERIMENTAL
Intervention: Amoxicillin administered as a bolus (375 mg in 120 ml water)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Amoxicillin administered as a 4-hour infusion (375 mg in 120 ml water)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Amoxicillin administered as a bolus in the ileum
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Amoxicillin administered as a 4-hour infusion in the ileum
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Amoxicillin infused in colonic regions
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Oral dose of amoxicillin solution
Number of subjects: 9
Study: 31942838

Group type: EXPERIMENTAL
Intervention: 400 mg grape seed polyphenol extract (GSPE)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 31469220

Group type: EXPERIMENTAL
Intervention: EQW + Plb
Number of subjects: 678

Group type: EXPERIMENTAL
Intervention: Dapa + Plb
Number of subjects: 678

Group type: EXPERIMENTAL
Intervention: EQW + Dapa
Number of subjects: 678

Group type: EXPERIMENTAL
Intervention: Dapa
Number of subjects: 678
Study: 30488853

Group type: EXPERIMENTAL
Intervention: Moderate supervised aerobic training, 3 days per week for 6 months
Number of subjects: 41

Group type: COMPARATOR
Intervention: Control group (no change in physical activity)
Number of subjects: 41
Study: 27521807

Group type: EXPERIMENTAL
Intervention: Take Control
Number of subjects: 311

Group type: COMPARATOR
Intervention: Therapist-Delivered Platforms (TDP)
Number of subjects: 311
Study: 24962353

Group type: EXPERIMENTAL
Intervention: ED-initiated palliative care referral
Number of subjects: 125

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 125
Study: 22882753

Group type: EXPERIMENTAL
Intervention: 50 mg sumatriptan tablet with 50 mL of water
Number of subjects: 10

Group type: COMPARATOR
Intervention: 50 mL of water alone (control)
Number of subjects: 10
Study: 20335070

Group type: EXPERIMENTAL
Intervention: Clopidogrel (300 mg for the first day, then 75 mg daily) plus aspirin (75-160 mg daily)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Aspirin alone (75-160 mg daily)
Number of subjects: 100
Study: 18822200

Group type: EXPERIMENTAL
Intervention: Telbivudine
Number of subjects: 80

Group type: COMPARATOR
Intervention: Entecavir
Number of subjects: 80
Study: 17002742

Group type: EXPERIMENTAL
Intervention: KetacCem (Group A)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Panavia21EX (Group B)
Number of subjects: 32
Study: 14576377

Group type: EXPERIMENTAL
Intervention: Stroke patients
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 100
Study: 11291603

Group type: EXPERIMENTAL
Intervention: IDDM patients
Number of subjects: 25

Group type: COMPARATOR
Intervention: Healthy volunteers (control group)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Valsalva tests and deep breathing HR response tests
Number of subjects: 25
Study: 8970679

Group type: EXPERIMENTAL
Intervention: ZDV/ddC/3TC (n = 15)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: ZDV/3TC (n = 15)
Number of subjects: 46

Group type: COMPARATOR
Intervention: ZDV/ddC (control group; n = 16)
Number of subjects: 46
Study: 1344237

Group type: EXPERIMENTAL
Intervention: Breathing through a simple face mask with an oxygen inflow of 6L/min (Group II)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Breathing oxygen with a flow rate of 10L/min through a simple face mask (Group III)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Breathing room air (Group I)
Number of subjects: 45
Study: 6199271

Group type: EXPERIMENTAL
Intervention: prajmalin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: propafenone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: disopyramide
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: sparteine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: nitroglycerin
Number of subjects: 0
Study: 29283916

Group type: EXPERIMENTAL
Intervention: Esophageal warming (fluid at 42°C)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Esophageal cooling (exchanger fluid at 7°C)
Number of subjects: 19
Study: 27496921

Group type: EXPERIMENTAL
Intervention: Wii exercise programme
Number of subjects: 80

Group type: COMPARATOR
Intervention: Gym-based exercise intervention
Number of subjects: 80
Study: 25739245

Group type: EXPERIMENTAL
Intervention: Titanium elastic nail (TEN)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Plate-screw fixation (PF)
Number of subjects: 32
Study: 23919320

Group type: EXPERIMENTAL
Intervention: Neuroleptics
Number of subjects: 1763

Group type: EXPERIMENTAL
Intervention: Heart failure with symptoms
Number of subjects: 1763

Group type: EXPERIMENTAL
Intervention: Low walking speed
Number of subjects: 1763

Group type: EXPERIMENTAL
Intervention: Reduced mobility (PCA component)
Number of subjects: 1763

Group type: EXPERIMENTAL
Intervention: Heart dysfunction (PCA component)
Number of subjects: 1763

Group type: EXPERIMENTAL
Intervention: Functional impairment including nocturia (PCA component)
Number of subjects: 1763
Study: 20428723

Group type: EXPERIMENTAL
Intervention: Exercise 1 (E1: 20 minutes)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Exercise 2 (E2: 40 minutes)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control (C: 40 minutes)
Number of subjects: 16
Study: 19290473

Group type: EXPERIMENTAL
Intervention: Lornoxicam 8 mg i.v. at the end of the operation, followed by 8 mg 12 h after the operation
Number of subjects: 160

Group type: COMPARATOR
Intervention: Tramadol 1 mg/kg at the end of the operation and every 6 h up to 24 h postoperatively
Number of subjects: 160
Study: 15838759

Group type: EXPERIMENTAL
Intervention: T1-weighted inversion recovery (IR)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: T1-weighted spin-echo (SE)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: T1-weighted gradient echo (GE)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Contrast-enhanced gradient echo (CE-GE)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Contrast-enhanced spin-echo (CE-SE)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: CNR of basal ganglia for IR
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: CNR of cortex for IR
Number of subjects: 31
Study: 12610744

Group type: EXPERIMENTAL
Intervention: Lamotrigine (LTG) 2.5 microg/ml
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Lamotrigine (LTG) 10 microg/ml
Number of subjects: 10

Group type: COMPARATOR
Intervention: Reference compound antipyrine (100 microg/ml)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Maternal vein and cord blood samples from epileptic mothers
Number of subjects: 10
Study: 10582898

Group type: EXPERIMENTAL
Intervention: Oral trovafloxacin (200 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Intravenous alatrofloxacin
Number of subjects: 12
Study: 8692619

Group type: EXPERIMENTAL
Intervention: Dexamethasone (0.5 mg/kg per day for 12 days, tapered progressively)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 70

Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 70
Study: 1879386

Group type: EXPERIMENTAL
Intervention: Seventeen meals daily
Number of subjects: 7

Group type: COMPARATOR
Intervention: Three meals daily
Number of subjects: 7
Study: 6603716

Group type: EXPERIMENTAL
Intervention: Netilmicin (5 mg/kg body weight, intramuscular injection)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Netilmicin combined with beta-Lactam antibiotics
Number of subjects: 0

Group type: COMPARATOR
Intervention: Newer aminoglycosides
Number of subjects: 0
Study: 30905227

Group type: EXPERIMENTAL
Intervention: Long-term antenatal indomethacin treatment (LIT)
Number of subjects: 166

Group type: COMPARATOR
Intervention: Control (unexposed neonates)
Number of subjects: 166
Study: 29767754

Group type: EXPERIMENTAL
Intervention: Clomiphene
Number of subjects: 900

Group type: EXPERIMENTAL
Intervention: Letrozole
Number of subjects: 900

Group type: EXPERIMENTAL
Intervention: Gonadotropins
Number of subjects: 900

Group type: EXPERIMENTAL
Intervention: OS‐IUI cycles (all treatments)
Number of subjects: 900
Study: 27527730

Group type: EXPERIMENTAL
Intervention: face-to-face contact + educational lecture
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: video-based contact + educational lecture
Number of subjects: 102
Study: 23231528

Group type: EXPERIMENTAL
Intervention: Individualized management program group
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 22608476

Group type: EXPERIMENTAL
Intervention: HSK eyes with severe sensation loss
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: HSK eyes
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: HSK eyes with normal sensation
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: HSK eyes with mild sensation loss
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control eyes
Number of subjects: 31
Study: 20535658

Group type: EXPERIMENTAL
Intervention: 1 day/wk interval training at 110-120% of peak workload
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 2 days/wk interval training at 110-120% of peak workload
Number of subjects: 20
Study: 18267054

Group type: EXPERIMENTAL
Intervention: Bimatoprost 0.03%
Number of subjects: 19

Group type: COMPARATOR
Intervention: Travoprost 0.004%
Number of subjects: 19
Study: 17316487

Group type: EXPERIMENTAL
Intervention: E‐Zagreb, L‐Zagreb, and Wistar RA 27/3 (Tresivac)
Number of subjects: 692

Group type: EXPERIMENTAL
Intervention: Moraten, J‐Lynn, and Wistar RA 27/3 (M‐M‐R II)
Number of subjects: 692

Group type: EXPERIMENTAL
Intervention: Schwarz, Urabe AM‐9, and Wistar RA 27/3 (Trimovax)
Number of subjects: 692

Group type: COMPARATOR
Intervention: Not applicable (before vaccination)
Number of subjects: 692
Study: 12611835

Group type: EXPERIMENTAL
Intervention: Pregabalin 150 mg/day
Number of subjects: 276

Group type: EXPERIMENTAL
Intervention: Pregabalin 600 mg/day
Number of subjects: 276

Group type: EXPERIMENTAL
Intervention: Lorazepam 6 mg/day
Number of subjects: 276

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 276
Study: 11098967

Group type: EXPERIMENTAL
Intervention: Assisted spontaneous breathing
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Synchronized intermittent mandatory ventilation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Biphasic positive airway pressure
Number of subjects: 0
Study: 9343646

Group type: EXPERIMENTAL
Intervention: 1 mg intra-articular morphine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 5 mg intra-articular morphine
Number of subjects: 0

Group type: COMPARATOR
Intervention: 5 mg intravenous morphine
Number of subjects: 0

Group type: COMPARATOR
Intervention: 100 mg bupivacaine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 0
Study: 8338088

Group type: EXPERIMENTAL
Intervention: Oral sodium phosphate (Fleet Phospho‐Soda)
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Lemon‐flavored castor oil (Purge)
Number of subjects: 113

Group type: COMPARATOR
Intervention: Standard polyethylene glycol‐based lavage solution (GoLYTELY)
Number of subjects: 113
Study: 3505526

Group type: EXPERIMENTAL
Intervention: Verapamil 5 mg/2 ml
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Verapamil 10 mg/4 ml
Number of subjects: 0

Group type: COMPARATOR
Intervention: Saline solution (placebo)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Verapamil (both dosages)
Number of subjects: 0
Study: 31702836

Group type: EXPERIMENTAL
Intervention: Lenalidomide maintenance therapy
Number of subjects: 457

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 457
Study: 30522665

Group type: EXPERIMENTAL
Intervention: Restore DCB
Number of subjects: 240

Group type: COMPARATOR
Intervention: SeQuent Please DCB
Number of subjects: 240
Study: 27345534

Group type: EXPERIMENTAL
Intervention: Fibrin glue for fixation of the mesh
Number of subjects: 116

Group type: COMPARATOR
Intervention: Polypropylene sutures (prolene 2/0) for mesh fixation
Number of subjects: 116
Study: 24077960

Group type: EXPERIMENTAL
Intervention: Basic intervention (educational meeting)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Extended intervention (two group detailing sessions)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Basic intervention
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Extended intervention
Number of subjects: 12
Study: 22048697

Group type: EXPERIMENTAL
Intervention: Algorithm-based sedation management
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 100
Study: 20117703

Group type: EXPERIMENTAL
Intervention: Aspheric Tecnis ZA9003 intraocular lens (IOL)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Spherical Sensar AR40e intraocular lens (IOL)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both IOLs
Number of subjects: 60
Study: 17493564

Group type: EXPERIMENTAL
Intervention: Intervention centers (15 centers)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Comparison centers (4 centers)
Number of subjects: 19
Study: 15901518

Group type: EXPERIMENTAL
Intervention: Single 2- to 3-minute scripted motivational counseling intervention delivered by physicians with an educational brochure and discount helmet coupon
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 200
Study: 11931132

Group type: EXPERIMENTAL
Intervention: Resin-modified glass ionomer (Fuji II LC)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Resin composite (Z250/Single Bond)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Both materials
Number of subjects: 37
Study: 10633481

Group type: EXPERIMENTAL
Intervention: Tryptophan-enhanced amino acid drink
Number of subjects: 28

Group type: COMPARATOR
Intervention: Tryptophan-depleted amino acid drink
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 28

Group type: COMPARATOR
Intervention: Tryptophan-depleted subjects
Number of subjects: 28

Group type: COMPARATOR
Intervention: Tryptophan-depleted subjects with high scores on Behavioral-Activation-System-Drive
Number of subjects: 28

Group type: COMPARATOR
Intervention: Tryptophan-depleted subjects scoring high on Buss-Durkee Hostility Inventory Assault and Guilt
Number of subjects: 28
Study: 7793215

Group type: EXPERIMENTAL
Intervention: Vecuronium
Number of subjects: 27

Group type: COMPARATOR
Intervention: Pancuronium
Number of subjects: 27

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 27
Study: 1838690

Group type: EXPERIMENTAL
Intervention: Atrial natriuretic factor (ANF) infusion (0.04 micrograms/kg/min)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Vehicle (50 mL of isotonic saline)
Number of subjects: 32
Study: 6217950

Group type: EXPERIMENTAL
Intervention: 1.0 g mezlocillin
Number of subjects: 149

Group type: COMPARATOR
Intervention: 2.0 g ampicillin plus 1.0 g probenecid orally
Number of subjects: 149

Group type: COMPARATOR
Intervention: 1.8 mega units of procaine penicillin
Number of subjects: 149
Study: 30117342

Group type: EXPERIMENTAL
Intervention: Coaching intervention in intervention communities
Number of subjects: 14

Group type: COMPARATOR
Intervention: Comparison communities
Number of subjects: 14
Study: 31774955

Group type: EXPERIMENTAL
Intervention: Levetiracetam
Number of subjects: 384

Group type: EXPERIMENTAL
Intervention: Fosphenytoin
Number of subjects: 384

Group type: EXPERIMENTAL
Intervention: Valproate
Number of subjects: 384
Study: 28784657

Group type: EXPERIMENTAL
Intervention: Cholecalciferol (2000 IU daily)
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Calcitriol (0.5 μg daily)
Number of subjects: 128

Group type: COMPARATOR
Intervention: Cholecalciferol
Number of subjects: 128

Group type: COMPARATOR
Intervention: Calcitriol
Number of subjects: 128
Study: 26393990

Group type: COMPARATOR
Intervention: Musical auditory stimulation in the control group (12 women not taking oral contraceptives)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Musical auditory stimulation in the oral contraceptive group (10 women taking oral contraceptives)
Number of subjects: 22
Study: 24038913

Group type: EXPERIMENTAL
Intervention: <3 years treated with intent to avoid irradiation
Number of subjects: 83

Group type: COMPARATOR
Intervention: 3-6 years treated with irradiation and chemotherapy
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 83
Study: 22561734

Group type: EXPERIMENTAL
Intervention: High lipid meal (LM)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: High carbohydrate meal (CM)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: High protein meal (PM)
Number of subjects: 18
Study: 20572765

Group type: EXPERIMENTAL
Intervention: Essential oil‐containing antiseptic (EO)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Oral administration of azithromycin (AZM)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (no adjunctive treatment)
Number of subjects: 30
Study: 18055985

Group type: COMPARATOR
Intervention: Chemotherapy
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: ASCT
Number of subjects: 45

Group type: COMPARATOR
Intervention: Induction courses
Number of subjects: 45

Group type: COMPARATOR
Intervention: HDT
Number of subjects: 45
Study: 16053784

Group type: EXPERIMENTAL
Intervention: Radiofrequency ablation
Number of subjects: 16
Study: 12404692

Group type: EXPERIMENTAL
Intervention: 0.66 g/kg alcohol
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: caffeine (110-120 mg)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: both alcohol and caffeine
Number of subjects: 64

Group type: COMPARATOR
Intervention: neither alcohol nor caffeine (placebo)
Number of subjects: 64
Study: 10192973

Group type: EXPERIMENTAL
Intervention: Nebivolol 5 mg once daily
Number of subjects: 0

Group type: COMPARATOR
Intervention: Enalapril 10 mg once daily
Number of subjects: 0
Study: 8669216

Group type: EXPERIMENTAL
Intervention: Morphine PCA (2 mg/ml or 3 mg/ml)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Morphine PCA
Number of subjects: 40
Study: 2178869

Group type: EXPERIMENTAL
Intervention: Acetyl-l-carnitine (1 g twice daily)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Acetyl-l-carnitine
Number of subjects: 36
Study: 6626853

Group type: EXPERIMENTAL
Intervention: imipramine and programmed in‐vivo exposure practice (I+BT)
Number of subjects: 18

Group type: COMPARATOR
Intervention: imipramine (I)
Number of subjects: 18
Study: 31937088

Group type: EXPERIMENTAL
Intervention: Ureteral catheter removed after 15 days (Group 1)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Ureteral catheter removed after 30 days (Group 2)
Number of subjects: 90
Study: 30839477

Group type: EXPERIMENTAL
Intervention: Healthy Hip Diaper (prophylactic treatment)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Observation only (control)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Overall (both groups)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Healthy Hip Diaper
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Not applicable
Number of subjects: 90
Study: 28802619

Group type: EXPERIMENTAL
Intervention: Sugammadex 2.0 mg/kg at T2 after rocuronium
Number of subjects: 1855

Group type: COMPARATOR
Intervention: Neostigmine at T2 after rocuronium
Number of subjects: 1855

Group type: EXPERIMENTAL
Intervention: Sugammadex 2.0 mg/kg at T2 after vecuronium
Number of subjects: 1855

Group type: COMPARATOR
Intervention: Neostigmine at T2 after vecuronium
Number of subjects: 1855

Group type: EXPERIMENTAL
Intervention: Sugammadex 4.0 mg/kg at 1–2 PTC after rocuronium
Number of subjects: 1855

Group type: COMPARATOR
Intervention: Neostigmine at 1–2 PTC after rocuronium
Number of subjects: 1855

Group type: EXPERIMENTAL
Intervention: Sugammadex 4.0 mg/kg at 1–2 PTC after vecuronium
Number of subjects: 1855

Group type: COMPARATOR
Intervention: Neostigmine at 1–2 PTC after vecuronium
Number of subjects: 1855

Group type: EXPERIMENTAL
Intervention: Sugammadex 16.0 mg/kg at 3 min after rocuronium 1.2 mg/kg
Number of subjects: 1855
Study: 26109079

Group type: EXPERIMENTAL
Intervention: Nattokinase (NK) 2,000 FU
Number of subjects: 12
Study: 24384878

Group type: EXPERIMENTAL
Intervention: Transobturator tape (TOT) procedure
Number of subjects: 138
Study: 23018466

Group type: EXPERIMENTAL
Intervention: Subcutaneous bortezomib 1.3 mg/m²
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intravenous bortezomib 1.3 mg/m²
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Subcutaneous bortezomib 1.3 mg/m² (CAN-1004)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intravenous bortezomib 1.3 mg/m² (CAN-1004)
Number of subjects: 0
Study: 19686880

Group type: EXPERIMENTAL
Intervention: Short 10-item FMD questionnaire
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 22-item FMD rating scale
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Therapeutic intervention (not specified)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 19839949

Group type: EXPERIMENTAL
Intervention: Unilateral lumbar paravertebral block (PVB)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional spinal anaesthesia (SA)
Number of subjects: 60